53 results
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
5 Mar 24
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
anesthetics, or continue to have persistent seizures on high-dose IV anesthetics Anoxic brain injury or an uncorrected rapidly reversible metabolic
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
4 Jan 24
Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY® Net Product Revenue and Provides Business Update
7:04am
<24 hours More than 18 hours of high-dose IV anesthetics, or continue to have persistent seizures on high-dose IV anesthetics Anoxic brain injury
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
28 Nov 23
Other Events
7:05am
persistent seizures on high-dose IV anesthetics Anoxic brain injury or an uncorrected rapidly reversible metabolic condition as the primary cause of SE
8-K
EX-99.2
vwdxzd
7 Nov 23
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
7:11am
8-K
EX-99.1
dkoqt7blv 44
28 Sep 23
Other Events
7:05am
8-K
EX-99.2
x3cnlsb8
10 Aug 23
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
7:10am
8-K
EX-99.2
urxaq zm2
11 May 23
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
7:03am
8-K
EX-99.2
zdliztd
7 Nov 22
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:01pm
8-K
EX-10.1
0cx0 xgw9l
3 Mar 22
Entry into a Material Definitive Agreement
4:05pm